tiprankstipranks
Trending News
More News >

Jacobson Pharma Reports Strong Financial Growth in 2025

Story Highlights
Jacobson Pharma Reports Strong Financial Growth in 2025

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Jacobson Pharma Corporation Limited ( (HK:2633) ).

Jacobson Pharma Corporation Limited announced its annual financial results for the year ending March 31, 2025, reporting a revenue increase of 7.4% to approximately HK$1,576.9 million. The company’s profit from operations rose by 24.5% to HK$414.6 million, and profit from continuing operations increased by 43.1% to HK$300.8 million. The Board has recommended a final cash dividend of HK5.50 cents per share and a special cash dividend of HK6.00 cents per share, reflecting a strong financial performance and commitment to returning value to shareholders.

More about Jacobson Pharma Corporation Limited

Jacobson Pharma Corporation Limited is a pharmaceutical company incorporated in the Cayman Islands. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.

Average Trading Volume: 880,176

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.57B

For an in-depth examination of 2633 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1